Acrel Co., Ltd. (300286.SZ) actual controller Zhou Zhong plans to increase the company's shares by 5 to 10 million yuan.
Ancore (300286.SZ) announced that the company's controlling shareholder, actual controller, chairman Mr. Zhou Zhong, and director, deputy general manager Ms. Zhu Fang, increased their holdings of the company's shares by 393,000 shares through the Shenzhen Stock Exchange trading system in a centralized bidding manner on July 21, 2026. Mr. Zhou Zhong plans to increase his holdings of the company's shares through the Shenzhen Stock Exchange trading system in a centralized bidding manner within 6 months from the date of this announcement. The total planned amount of the increase should not be less than RMB 5 million and not exceed RMB 10 million ( including the amount already increased on July 21, 2026).
Acrel Co., Ltd. (300286.SZ) announced that its controlling shareholder, actual controller, chairman Mr. Zhou Zhong, and director, deputy general manager Ms. Zhu Fang, increased their holdings of the company by 393,000 shares on July 21, 2026 through the Shenzhen Stock Exchange trading system in a centralized bidding transaction. Mr. Zhou Zhong plans to continue increasing his holdings of the company's stock through the Shenzhen Stock Exchange trading system in a centralized bidding manner within 6 months from the date of this increase plan announcement. The total planned amount for the increase is not less than RMB 5 million and not more than RMB 10 million (including the amount already increased on July 21, 2026).
Related Articles
US Stock Market Move | Halliburton (HAL.US) fell nearly 6% as Q3 revenue guidance weakened.
US Stock Market Move | Tesla, Inc. (TSLA.US) rises more than 3%, the market expects a year-on-year increase of nearly 30% in Q2 earnings per share.
SUNHO BIO-B(02898): Fan Rongkui terminates his appointment as non-executive director.
US Stock Market Move | Halliburton (HAL.US) fell nearly 6% as Q3 revenue guidance weakened.
US Stock Market Move | Tesla, Inc. (TSLA.US) rises more than 3%, the market expects a year-on-year increase of nearly 30% in Q2 earnings per share.
SUNHO BIO-B(02898): Fan Rongkui terminates his appointment as non-executive director.
RECOMMEND
